Gluferal is an anticonvulsant from the group of barbiturates.
Producing countries: Georgia (Tbilisi Chemical Plant), Russia (Fitofarm-NN).
Dosage form: tablets.
Compound:
- phenobarbital - 0.025 g
- caffeine-sodium benzoate - 0.005 g
- Brominated - 0.07 g
- calcium gluconate - 0.2 g
Indications for use: epilepsy, epileptic seizures (petit mal).
No contraindications have been identified.
Side effects: drowsiness in the first days of treatment.
There is no information about drug interactions.
An overdose causes dizziness and unsteadiness of gait.
No special instructions for use are required.
Literature: Directory "Medicines" edited by M.A. Klyueva, 2001